Cite this article
Volume | Year
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Rosacea fulminans during pregnancy
A.G. Markou1, *, V. Alessandrini1, J.M. Muray1, E. Begon2, M. Fysekidis3
1 Department of Obstetrics and Gynecology, René DUBOS Hospital, Cergy-Pontoise cedex, France
2 Department of Dermatology, René DUBOS Hospital, Cergy-Pontoise cedex, France
3 Diabetes, Nutrition and Endocrinology Department, Avicenne Hospital, Bobigny, France
Clin. Exp. Obstet. Gynecol. 2017, 44(1), 157–159; https://doi.org/10.12891/ceog3343.2017
Published: 10 February 2017
Background: Rosacea fulminans (RF) is a severe form of facial dermatosis presenting with a sudden onset of numerous facial pustules, papules, and erythema. During pregnancy its treatment may be difficult and can have an impact on obstetrical outcomes. Case: A 37-year-old woman during the 37th week of her fourth pregnancy presented RF that was associated with ocular manifestations. The usual treatment with isotretinoin was contraindicated during pregnancy and the patient started an alternative treatment with prednisone and azithromycin. After delivery at 38 weeks of gestational age, there was a significant improvement. Conclusion: RF is a severe dermatological disease with unknown etiology and with a rapid improvement in the immediate postpartum period.